Shin Nippon Biomedical Laboratories (STU:YB3) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:YB3 Shin Nippon Biomedical Laboratories Ltd STU:YB3
73 GF Score
Price €7.20
GF Value €9.64
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Net Loan?

Net Loan only applies to banks and insurance companies.

STU:YB3
73GF Score
Shin Nippon Biomedical Laboratories Ltd STU:YB3
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shin Nippon Biomedical Laboratories (STU:YB3) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of €7.20 is trading 25.3% below its estimated GF Value™ of €9.64.

Key valuation signals for STU:YB3:

  • Net Loan:
  • GF Value™: €9.64 vs. price of €7.20 (25.3% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the STU:YB3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:Japan
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
73GF Score

Get the complete analysis for STU:YB3

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.20
Price
€9.64
GF Value